Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Clinical Investigation

• Publication date

  1986-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI112406PMID 3082933PMCID PMC424441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypertriglyceridemia.

  2006cited by this paper
• Assay of cholesteryl ester transfer activity and purification of a cholesteryl ester transfer protein.

  1985cited by this paper
• The origin and properties of free cholesterol potential gradients in plasma, and their relation to atherogenesis.

  1984cited by this paper
• Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer.

  1984cited by this paper
• Continuous ambulatory peritoneal dialysis: three years' experience.

  1983cited by this paper
• Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.

  1983cited by this paper
• Metabolic consequences of antihypertensive therapy.

  1983cited by this paper
• Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis. A possible mechanism for accelerated atherosclerosis in white men.

  1983cited by this paper
• Putative atherogenic factors in patients with chronic renal failure.

  1983cited by this paper
• Assessment of nutritional status of the National Cooperative Dialysis Study population.

  1983cited by this paper
• Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.

  1983cited by this paper
• Surface-to-core and interparticle equilibrium distributions of triglyceride-rich lipoprotein lipids.

  1983cited by this paper
• Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.

  1983cited by this paper
• Subfractionation of human very low density lipoproteins by heparin-Sepharose affinity chromatography.

  1983cited by this paper
• Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency.

  1982cited by this paper
• Kinetics of plasma protein-catalyzed exchange of phosphatidylcholine and cholesteryl ester between plasma lipoproteins.

  1982cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

  1982cited by this paper
• Plasma Lipid and Lipoprotein Levels in Patients Treated with CAPD

  1981cited by this paper
• Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase.

  1981cited by this paper
• [Chronic ambulatory peritoneal dialysis].

  1981cited by this paper
• Regulation of human plasma lecithin:cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content.

  1981cited by this paper
• Rise in High-Density Lipoprotein-Cholesterol in Some Patients Treated with CAPD

  1980cited by this paper
• A cholesteryl ester transfer complex in human plasma.

  1980cited by this paper
• Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.

  1979cited by this paper
• Plasma Lipid Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study THE LIPID RESEARCH CLINICS PROGRAM EPIDEMIOLOGY COMMITTEE

  1979cited by this paper
• Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis.

  1978cited by this paper
• Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia.

  1978cited by this paper
• Human plasma lecithin-cholesterol acyltransferase. Characterization of cofactor-dependent phospholipase activity.

  1978cited by this paper
• The picomole determination of free and total cholesterol in cells in culture.

  1978cited by this paper
• Prevalence of serum lipid abnormalities in chronic hemodialysis.

  1977cited by this paper
• The interaction of heparin with an apoprotein of human very low density lipoprotein.

  1977cited by this paper
• Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia.

  1977cited by this paper
• The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.

  1977cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper
• Editoral: Cardiovascular disease in dialysis patients.

  1974cited by this paper
• Hypertriglyceridemia. A metabolic consequence of chronic renal failure.

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The role of lipoprotein (a) in chronic kidney disease

  2018cites this paper
• DYSLIPIDEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE

  2017cites this paper
• Lipoprotein (a): impact by ethnicity and environmental and medical conditions

  2016cites this paper
• Dialysis Modalities and HDL Composition and Function.

  2015cites this paper
• Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin.

  2013cites this paper
• Cholesterol metabolism in patients with hemodialysis in the presence or absence of coronary artery disease.

  2012cites this paper
• New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins from in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease

  2012cites this paper
• Coronary risk factors in maintenance hemodialysis patients: Who is the culprit – hemodialysis or chronic renal failure?

  2011cites this paper
• Emerging risk factors and markers of chronic kidney disease progression

  2009cites this paper
• Lipid profile and concentration of ApoA-1 and ApoB-100 in patients with end-stage renal disease treated by repeated haemodialysis.

  2008cites this paper
• Reverse Epidemiology: A Confusing, Confounding, and Inaccurate Term

  2007cites this paper
• Endocrinology and Dialysis
Jean L. HolleySeries Editor: Lipid Abnormalities Associated with End‐Stage Renal Disease

  2006cites this paper
• Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria Published, JLR Papers in Press, June 20, 2006.

  2006cites this paper
• Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis

  2005cites this paper
• Preventing Cardiovascular Outcome in Patients with Renal Impairment

  2005cites this paper
• Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density

  2005cites this paper
• Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.

  2004cites this paper
• Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients

  2004cites this paper
• Lipids and atherosclerosis

  2004cites this paper
• Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study.

  2004cites this paper
• Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.

  2003cites this paper
• Low density lipoproteins and mitogenic signal transduction processes: role in the pathogenesis of renal disease.

  2002cites this paper
• Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.

  2001cites this paper
• Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease.

  2001cites this paper
• Levels of cholesteryl esters and other lipids in the plasma of patients with end-stage renal failure.

  2001cites this paper
• Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.

  2000cites this paper
• Peritoneal Dialysis in Children: Issues for the 21St Century

  1999influential citation
• Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.

  1999cites this paper
• The atherogenic lipoprotein phenotype in renal disease

  1999cites this paper
• Genesis of Atherosclerosis in Uremic Patients

  1999cites this paper
• Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.

  1999cites this paper
• Effects of acetate or bicarbonate dialysis solutions on serum HDL and HDL subfractions of patients undergoing haemodialysis.

  1999cites this paper
• An Overview of Haemodialysis and Oxidant Stress

  1999cites this paper
• Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes.

  1998cites this paper
• Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.

  1998cites this paper
• Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus.

  1998cites this paper
• Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients.

  1998cites this paper
• Hyperlipidemia in patients with chronic renal disease.

  1998cites this paper
• Pyrazinoylguanidine in End-Stage Renal Disease: A Prospective, Placebo-Controlled Pilot Study

  1998cites this paper
• Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

  1998cites this paper
• The interaction of modified low density lipoproteins with glomerular mesangial cells and its potential influence on glomerulosclerosis

  1998cites this paper
• The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure.

  1997cites this paper
• Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group.

  1997cites this paper
• Residual Renal Function Affects Lipid Profile in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

  1997cites this paper
• Atherogenic lipoproteins and human disease: extending concepts beyond the heart to the kidney.

  1997cites this paper
• Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.

  1997cites this paper
• High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis.

  1997cites this paper
• Is Capd Atherogenic?

  1997cites this paper
• Atherosclerosis and arteriosclerosis in chronic renal failure.

  1997cites this paper
• Reverse cholesterol transport: its contribution to cholesterol catabolism in normal and disease states.

  1996cites this paper
• Dyslipidemia in renal disease.

  1996cites this paper
• Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis.

  1996cites this paper
• Increased activity of plasma cholesteryl ester transfer protein in children with end-stage renal disease receiving continuous ambulatory peritoneal dialysis.

  1996cites this paper
• Lipoprotein(a) in renal disease.

  1996cites this paper
• Diagnosis and classification of dyslipidemia in renal disease.

  1996cites this paper
• Lipoprotein metabolism in renal replacement therapy: a review.

  1996cites this paper
• Alterations of HDL subfractions in patients with Balkan endemic nephropathy and in healthy family members.

  1996cites this paper
• Abnormalities of lipoprotein metabolism in CAPD patients.

  1996cites this paper
• Role of an N-ethylmaleimide-sensitive factor in the selective cellular uptake of low-density lipoprotein free cholesterol.

  1995cites this paper
• Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.

  1995cites this paper
• Lower serum high-density lipoprotein-cholesterol concentration in patients undergoing maintenance hemodialysis with acetate than with bicarbonate.

  1995cites this paper
• Cholesteryl ester transfer in patients with renal failure or renal transplants.

  1994cites this paper
• Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.

  1994cites this paper
• Mechanism of the gemfibrozil-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins.

  1994cites this paper
• Decreased clearance of low-density lipoprotein in patients with chronic renal failure.

  1994cites this paper
• Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies.

  1994cites this paper
• Two-site enzyme immunoassay of cholesteryl ester transfer protein with monoclonal and oligoclonal antibodies.

  1994cites this paper
• [Transfer of plasma cholesterol and atherosclerosis].

  1994cites this paper
• Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.

  1994cites this paper
• Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.

  1993cites this paper
• Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

  1993cites this paper
• Disturbances of lipid metabolism in children with chronic renal failure

  1993cites this paper
• Lipoprotein metabolism and renal failure.

  1993cites this paper
• Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil.

  1993cites this paper
• Lipoprotein heterogeneity in end-stage renal disease.

  1993cites this paper
• Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients.

  1993cites this paper
• The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.

  1993cites this paper
• Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

  1993cites this paper
• Catabolism of low-density lipoprotein is altered in experimental chronic renal failure.

  1993cites this paper
• Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease.

  1992cites this paper
• Impaired metabolism of high density lipoprotein in uremic patients.

  1992cites this paper
• Lipids and apolipoproteins change during the progression of chronic renal failure.

  1992cites this paper
• Cardiovascular risk factors in chronic renal failure and hemodialysis populations.

  1992cites this paper
• Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration

  1992cites this paper
• The uremic dyslipidemia: a cross-sectional and longitudinal study.

  1992cites this paper
• Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics.

  1992cites this paper
• Plasma apolipoprotein A‐IV metabolism in patients with chronic renal disease

  1992cites this paper
• Atherogenesis in Chronic Renal Failure

  1992cites this paper
• Lipid abnormalities in black renal patients.

  1991cites this paper
• Lipid abnormalities in chronic renal insufficiency.

  1991cites this paper
• Lipid abnormalities in renal disease.

  1991cites this paper
• Abnormalities of lipoprotein composition in renal insufficiency.

  1991cites this paper
• Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease.

  1991cites this paper
• Enhancement of the human plasma lipid transfer protein reaction by apolipoproteins.

  1991cites this paper
• Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.

  1991cites this paper
• Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.

  1991cites this paper
• Principal discussant: GERALD APPEL

  1991cites this paper
• Causes, Consequences, and Treatment of Hyperlipidemia in Patients with Renal Disease

  1990cites this paper
• Changes in the composition of plasma lipoproteins in the chronic uremic rat.

  1990cites this paper
• Interaction of lipid transfer protein with plasma lipoproteins and cell membranes

  1990cites this paper